Showing 2,381 - 2,400 results of 2,510 for search '"clinical researcher"', query time: 0.08s Refine Results
  1. 2381
  2. 2382
  3. 2383

    Extensive Inactive Neurocysticercosis: A Case Report in Mbeya, Southern Highlands of Tanzania by Makasi CE, Ngowi BJ, Stelzle D, Kilale AM, Mahande MJ, Welte TM, Winkler AS, Mmbaga BT

    Published 2025-01-01
    “…Charles Elias Makasi,1,2 Bernard James Ngowi,3 Dominik Stelzle,4 Andrew Martin Kilale,1 Michael Johnson Mahande,2,5 Tamara Margarete Welte,4 Andrea Sylvia Winkler,4,6 Blandina Theophil Mmbaga2,7 1National Institute for Medical Research, Muhimbili Medical Research Centre, Dar Es Salaam, Tanzania; 2Kilimanjaro Christian Medical University College of Tumaini University, Moshi, Tanzania; 3University of Dar Es Salaam, Mbeya College of Health and Allied Sciences, Mbeya, Tanzania; 4Department of Neurology and Center for Global Health, School of Medicine and Health, Technical University Munich, Munich, Germany; 5Department of Epidemiology and Biostatistics, Institute of Public Health, Kilimanjaro Christian Medical University College, Moshi, Tanzania; 6Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway; 7Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Moshi, TanzaniaCorrespondence: Charles Elias Makasi, Email charlesemakasi@gmail.comBackground: Neurocysticercosis (NCC) and Acquired Human Immunodeficiency Syndrome (AIDS) are both highly prevalent in Africa. …”
    Get full text
    Article
  4. 2384
  5. 2385
  6. 2386

    Efficacy and Safety of a Novel Low-Dose Water-Dispersible Turmeric Extract in the Management of Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial by Thanawala S, Shah R, Alluri KV, Bhupathiraju K, Prasad N, Agarwal Y

    Published 2025-01-01
    “…Shefali Thanawala,1 Rajat Shah,2 Krishnaraju Venkata Alluri,3 Kiran Bhupathiraju,4 Nandlal Prasad,5 Yash Agarwal6 1Medical Science and Research Department, Nutriventia Limited, Mumbai, Maharashtra, 400069, India; 2Executive Management, Nutriventia Limited, Mumbai, Maharashtra, 400069, India; 3Pharmacology and Clinical Research, Laila Nutraceuticals, Vijayawada, Andhra Pradesh, 520010, India; 4Research & Development, Laila Nutraceuticals, Vijayawada, Andhra Pradesh, 520010, India; 5Department of Orthopedics, Bajarang Memorial Fracture Accidental and Surgical Center, Varanasi, Uttar Pradesh, 221003, India; 6Department of Orthopedics, Sri Ram Ortho and Physio Rehab Centre, Varanasi, Uttar Pradesh, 221007, IndiaCorrespondence: Shefali Thanawala, Medical Science and Research Department, Unit 703 & 704, 7 th Floor Solaris One Premises Co-Operative Society Limited, N.S. …”
    Get full text
    Article
  7. 2387
  8. 2388

    Evaluation of Healthcare Outcomes of Patients Treated with 3D-Printed-Titanium and PEEK Cages During Fusion Procedures in the Lumbar Spine by Corso KA, Teferra AA, Michielli A, Corrado K, Marcini A, Lotito M, Smith C, Costa M, Ruppenkamp J, Wallace A

    Published 2025-01-01
    “…Katherine A Corso,1 Andreas A Teferra,1 Annalisa Michielli,2 Kristin Corrado,2 Amy Marcini,3 Mark Lotito,2 Caroline Smith,4 Michelle Costa,4 Jill Ruppenkamp,1 Anna Wallace1 1MedTech Epidemiology and Real-World Data Science, Johnson & Johnson, Raynham, Massachusetts & New Brunswick, New Jersey, USA; 2Clinical Research, DePuy Synthes, MedTech, Johnson & Johnson, Raynham, Massachusetts, USA; 3Medical Affairs, DePuy Synthes, MedTech, Johnson & Johnson, Raynham, Massachusetts, USA; 4Franchise HEMA, DePuy Synthes, Medtech, Johnson & Johnson, Raynham, Massachusetts, USACorrespondence: Katherine A Corso, MedTech Epidemiology and Real-world Data Science, Johnson & Johnson, 325 Paramount Drive, Raynham, MA, 02767, USA, Tel +1 857-523-0279, Email kcorso1@its.jnj.comPurpose: The objective of this observational, real-world study was to describe reoperation, revision, index healthcare utilization and hospital costs among patients treated with PEEK (polyetheretherketone) or 3D-printed-titanium cages during lumbar/lumbosacral posterior fusion procedures, either TLIF (transforaminal lumbar interbody fusion) or PLIF (posterior lumbar interbody fusion). …”
    Get full text
    Article
  9. 2389
  10. 2390
  11. 2391
  12. 2392

    A retrospective study of pembrolizumab combined with XELOX regimen in the treatment of advanced gastric cancer by FENG Huizhi, LIU Jingmei, BU Xiaoqian

    Published 2024-11-01
    “…Therefore, exploring effective treatment options remains a key focus of clinical research. As a new type of immune checkpoint inhibitor, the clinical efficacy and safety of pembrolizumab still need to be confirmed by extensive research. …”
    Get full text
    Article
  13. 2393
  14. 2394
  15. 2395
  16. 2396
  17. 2397
  18. 2398
  19. 2399
  20. 2400